EU · REG · 1223/2009 Consumer Advisory Est · MMXXVI
BANNED in Europe Banned in Europe
Explainers

Why European Sunscreens Have Been Better (and What the FDA Just Changed)

For 25 years the US was stuck with the same short list of UV filters while Europe used newer, better ones. In June 2026 that gap finally started to close. Here's the honest version, with the regulation that explains all of it.

By Updated June 19, 2026 8 min read Explainers

If you’ve ever bought sunscreen in a French pharmacy and felt like you were getting away with something, you’re not imagining it. The texture is lighter, it doesn’t leave a white cast, and it tends to hold up better against the kind of sun that ages your skin. For years, American travelers have come home with suitcases full of the stuff. The question is why a bottle of sunscreen should feel like contraband in the first place.

The short answer is regulation, not chemistry. And as of June 2026, the answer is starting to change.

Let me lay out what’s actually true here, because this is a topic where both the “European sunscreen is magic” crowd and the “American sunscreen is fine, stop worrying” crowd are each half right.

The US treats sunscreen as a drug. Europe treats it as a cosmetic.

This is the whole story in one sentence, and almost everything downstream follows from it.

In the European Union, sunscreens are regulated as cosmetics under Regulation (EC) No 1223/2009. A new UV filter goes through a safety review by the Scientific Committee on Consumer Safety, and once it clears, it gets added to Annex VI, the list of permitted filters. That list currently runs to roughly two to three dozen approved filters.

In the United States, sunscreen is an over-the-counter drug, governed by an FDA monograph. That sounds like a technicality. It is not. The drug pathway demands a far heavier safety dossier, including data on how much of the ingredient gets absorbed through your skin and into your bloodstream. The bar is higher, the paperwork is thicker, and the process moves at the pace of, well, a federal drug review.

The result: the FDA’s last approval of a genuinely new UV filter before 2026 was in 1999. More than a quarter century. In that window, European, Australian, and Asian formulators kept adding better filters, and American shelves stayed frozen with a roster of about sixteen.

If you want the deeper structural version of this story, it’s the same plot as REACH vs TSCA: the two systems made opposite default choices, and the products on the shelf are just the visible consequence.

What the US was actually missing: UVA protection

Here’s where the calibration matters, because “American sunscreen doesn’t work” is flatly false.

Sunlight gives you two kinds of ultraviolet trouble. UVB is the one that burns you. UVA is the one that penetrates deeper, drives most photoaging, and contributes to skin cancer without the early-warning sting of a sunburn. American sunscreens have always been good at blocking UVB. Their SPF numbers are real. The weak spot was UVA.

The main US chemical UVA filter, avobenzone, works, but it’s not the strongest option and it can degrade in light unless it’s carefully stabilized. The filters Europe had and the US didn’t, bemotrizinol (sold as Tinosorb S) and bisoctrizole (Tinosorb M), give broader, more photostable UVA coverage. Researchers comparing filters have repeatedly flagged bemotrizinol, bisoctrizole, ecamsule, and drometrizole trisiloxane as more effective than avobenzone for UVA. (EWG: Do other countries have better sunscreens?)

So the gap was real, and it sat exactly where it was hardest for a consumer to notice: not in whether you burned, but in the invisible, long-game damage.

And there’s a second, quieter half of the story. While Europe had filters the US lacked, the FDA was also looking sideways at some of the filters Americans had been using for decades. In its 2019 proposed rule, the agency said only two of the sixteen approved filters, zinc oxide and titanium dioxide, had enough data to be classified outright as “generally recognized as safe and effective.” For twelve others, including oxybenzone, the FDA said it simply needed more data, particularly on skin absorption. (FDA proposed rule context, via EWG)

Read that carefully, because the internet routinely gets it wrong. “Needs more data” is not “found to be dangerous.” This is the calm-skeptic point: the US sunscreen aisle wasn’t poisoning anyone, but it was running on filters the agency couldn’t fully vouch for and missing newer ones that the rest of the world had moved to. Both things were true at once.

What changed in June 2026

On June 10, 2026, the FDA issued a Final Administrative Order (OTC000039) adding bemotrizinol to the OTC sunscreen monograph, approved at concentrations up to 6% for adults and children six months and older, and effective August 9, 2026. (Federal Register; Scientific American) It’s the first new active sunscreen ingredient the US has approved in more than two decades.

The timeline is worth noting, both for how fast and how slow it was. DSM Nutritional Products submitted its request in September 2024. The FDA issued a proposed order in December 2025 and finalized it in June 2026. (CIRS Group regulatory summary) So once a complete dossier landed, the review took under two years. The 25-year drought wasn’t really about any single review being slow. It was about the dossier bar being so high that, for years, nobody completed the climb.

A few honest caveats before anyone reformulates their medicine cabinet:

Bemotrizinol is approved, but products containing it won’t appear overnight; manufacturers have to formulate, test, and manufacture to the new monograph. The bottle in your hand today still has the old filter list.

And bemotrizinol is one filter, not the whole European pharmacy. Bisoctrizole (Tinosorb M), the other marquee European UVA filter, still isn’t approved as an active sunscreen ingredient in the US, though it can show up as a cosmetic UV absorber in things like tinted moisturizers. (Grand Ingredients regulatory roundup) The gap narrowed. It didn’t vanish.

So should you still smuggle sunscreen back from Europe?

Less than you used to need to, and here’s the level-headed read.

If you already use a well-formulated American mineral sunscreen, zinc oxide or titanium dioxide, you have been getting solid broad-spectrum protection the whole time. Those two are the filters the FDA was always most comfortable with. The thing many people disliked about them was cosmetic: the white cast, the heavier feel. That’s a formulation complaint, not a protection one.

If your complaint was that European sunscreens simply felt better and seemed to handle UVA more gracefully, that was a fair read of a real difference, and it’s the part that’s now beginning to close.

The bigger lesson sits underneath the sunscreen aisle. This is one of the clearest cases on the whole site where “banned in Europe” gets the direction backward. The interesting gap here isn’t something Europe prohibited. It’s something Europe allowed, sooner, because its system says yes to a new ingredient once a manufacturer proves it’s safe, while the US system makes the manufacturer clear a much taller wall first. Same underlying question, opposite default answer. For most of the things this site covers, that default makes Europe stricter. For sunscreen, it made Europe faster. The honest version of “I feel better about European sunscreen” is really “I trust a system that updated its list this century.”

The US just updated its list too. About time.

Sources